Immuno-oncology (I-O), cancer immunotherapy, or biologic therapy is a type of cancer treatment that uses modified substances from a person's body to boost their natural defenses to fight cancer.
With the use of adoptive cell immunotherapy, many cancers such as Non-Hodgkin lymphoma, childhood Acute Lymphoblastic Leukemia, and Multiple Myeloma have had 80%-90% success in preventing remission after 6 months.
The global Immuno-oncology Therapy market was valued at nearly 43 billion dollars in 2016, and is projected to rise to nearly 97 billion by 2022.
More than 14 million people a year receive a cancer diagnosis, making cancer one of the world's most prevalent health concerns.
Leaders in the oncology field have selected immunotherapy as the Advance of the Year for two years in a row for the cancer fighting progress and amazing potential it demonstrates.